K
Karam Kostner
Researcher at University of Queensland
Publications - 160
Citations - 6301
Karam Kostner is an academic researcher from University of Queensland. The author has contributed to research in topics: Lipoprotein(a) & Lipoprotein. The author has an hindex of 35, co-authored 156 publications receiving 5595 citations. Previous affiliations of Karam Kostner include Mater Health Services & University of Vienna.
Papers
More filters
Journal ArticleDOI
Diagnostic Potential of Saliva: Current State and Future Applications
Tina Pfaffe,Justin J. Cooper-White,Peter Beyerlein,Karam Kostner,Karam Kostner,Chamindie Punyadeera +5 more
TL;DR: Saliva has the potential to become a first-line diagnostic sample of choice owing to the advancements in detection technologies coupled with combinations of biomolecules with clinical relevance as mentioned in this paper, however, these technologies have not yet been integrated into current clinical practice and work flow.
Journal ArticleDOI
Late prognostic value of flow-mediated dilation in the brachial artery of patients with chest pain.
Thomas Neunteufl,Sandra Heher,Reinhold Katzenschlager,Gabriele Wölfl,Karam Kostner,Gerald Maurer,Franz Weidinger +6 more
TL;DR: In this paper, Ross et al. showed that CRP levels do not correlate with the extent and severity of coronary narrowing assessed by angiography, and other mechanisms such as acute inflammation with plaque instability and rupture may explain the higher cardiovascular event rate in patients with elevated CRP.
Journal ArticleDOI
The Relative Benefits of Endurance and Strength Training on the Metabolic Factors and Muscle Function of People With Type 2 Diabetes Mellitus
Edmund Cauza,Ursula Hanusch-Enserer,Barbara Strasser,Bernhard Ludvik,Sylvia Metz-Schimmerl,Giovanni Pacini,Oswald Wagner,Petra Georg,Rudolf Prager,Karam Kostner,Attila Dunky,Paul Haber +11 more
TL;DR: ST was more effective than ET in improving glycemic control and has the added advantage of an improved lipid profile, which means that ST may play an important role in the treatment of T2D.
Journal ArticleDOI
Statin intolerance – an attempt at a unified definition. Position paper from an International Lipid Expert Panel
Maciej Banach,Manfredi Rizzo,Peter P. Toth,Michel Farnier,Michael H. Davidson,Khalid Al-Rasadi,Wilbert S. Aronow,Vasilis G. Athyros,Dragan M. Djuric,Marat V. Ezhov,Robert S. Greenfield,G. Kees Hovingh,Karam Kostner,Corina Serban,Daniel Lighezan,Zlatko Fras,Patrick M. Moriarty,Paul Muntner,Assen Goudev,Richard Ceska,Stephen J. Nicholls,Marlena Broncel,Dragana Nikolic,Daniel Pella,Raman Puri,Jacek Rysz,Nathan D. Wong,Laszlo Bajnok,Steven R. Jones,Kausik K. Ray,Dimitri P. Mikhailidis +30 more
TL;DR: The aim of this position paper was to suggest a unified definition of statin intolerance, and to complement the recent EAS statement on SAMS, where the pathophysiology, diagnosis and the management were comprehensively presented.
Journal ArticleDOI
Statin intolerance-an attempt at a unified definition. Position paper from an International Lipid Expert Panel
Maciej Banach,Manfredi Rizzo,Peter P. Toth,Michel Farnier,Michael H. Davidson,Khalid Al-Rasadi,Wilbert S. Aronow,Vasilis G. Athyros,Dragan M. Djuric,Marat V. Ezhov,Robert S. Greenfield,G. Kees Hovingh,Karam Kostner,Corina Serban,Daniel Lighezan,Zlatko Fras,Patrick M. Moriarty,Paul Muntner,Assen Goudev,Richard Ceska,Stephen J. Nicholls,Marlena Broncel,Dragana Nikolic,Daniel Pella,Raman Puri,Jacek Rysz,Nathan D. Wong,Laszlo Bajnok,Steven R. Jones,Kausik K. Ray,Dimitri P. Mikhailidis +30 more
TL;DR: The aim of this position paper was to suggest a unified definition of statin intolerance, and to complement the recent EAS statement on SAMS, where the pathophysiology, diagnosis and the management were comprehensively presented.